15 June 2020>: Clinical Research
Therapeutic Effect of Chemotherapy Cycle in Nasopharyngeal Carcinoma (NPC) Patients Who Developed Bone-Only Metastasis
Sikai Nong BCD , Xinbin Pan BCD , Kaihua Chen EF , Ye Li CD , Xiaodong Zhu AFG*DOI: 10.12659/MSM.922244
Med Sci Monit 2020; 26:e922244
Table 4 OS rates in the 2 patient groups.
Group | N | OS(%) | P-value | ||
---|---|---|---|---|---|
1-year | 2-year | 3-year | |||
29 | 64.8% | 34.3% | 17.2% | 0.042 | |
≥6-cycle | 29 | 92.6% | 54.9% | 30.9% |